Edwards Lifesciences Corporation Common Stock vs Planet Labs — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while Planet Labs trades at $17.32 (market cap $6.25B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 7.8× Planet Labs's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals.
| EW | PL | |
|---|---|---|
Market Cap | $48.56B | $6.25B |
Volume | 6,520,488 | 19,125,340 |
Sector | Health | Industrials |
52-Week High | $95.18 | $51.40 |
52-Week Low | $72.65 | $11.16 |
Enterprise Value | $45.01B | $5.89B |
Typical Hold Time | — | 4 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →